This was achieved by direct-tumour-injections, whereas systemic application of their FL-TRAIL carrying MSCs had no effect on the growth of colorectal cancer xenografts owing to a low rate of tumour integration of MSCs. This evidence concerns the gene TNFSF10 and colorectal cancer.